0
Views
0
CrossRef citations to date
0
Altmetric
Special Report

PTSD and mood disorders in implantable cardioverter defibrillator patients: is more psychological assessment needed?

, , , , , & show all
Received 07 Dec 2023, Accepted 25 Jul 2024, Published online: 01 Aug 2024

References

  • Kusumoto FM, Calkins H, Boehmer J, et al. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation. 2014;130(1):94–125. doi: 10.1161/CIR.0000000000000056
  • Januszkiewicz Ł, Barra S, Providencia R, et al. Long-term quality of life and acceptance of implantable cardioverter-defibrillator therapy: results of the European Heart Rhythm Association Survey. EHJ. 2022;24(5):860–867. doi: 10.1093/europace/euac011
  • Miranda J, Stiles M, Lever N, et al. Prevalence of depression and anxiety among patients with cardiac implantable electronic device (CIED). Heart Lung Circ. 2018;27:S13–4. doi: 10.1016/j.hlc.2018.05.129
  • Sears SF Jr, Todaro JF, Lewis TS, et al. Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clin Cardiol. 1999;22(7):481–489. doi: 10.1002/clc.4960220709
  • van der Lingen ACJ, Rijnierse MT, Hooghiemstra AM, et al. The link between cardiac status and depression and anxiety in implantable cardioverter defibrillator patients: design and first results of the PSYCHE-ICD study. J Psychosom Res. 2023;167:111182. doi: 10.1016/j.jpsychores.2023.111182
  • Ichikura K, Kobayashi S, Matsuoka S, et al. Avoidance behavior associated with depressive symptoms in patients with implantable cardioverter defibrillators. IJCHP. 2017;17(1):1–8. doi: 10.1016/j.ijchp.2016.11.001
  • Sall KE, Griffith AM, Midgette EP, et al. Cardiac psychology training in a rural health care setting: East Carolina Heart Institute. Health Phychol. 2022;41(10):803–812. doi: 10.1037/hea0001167
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi: 10.1046/j.1525-1497.2001.016009606.x
  • Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097. doi: 10.1001/archinte.166.10.1092
  • Sears SF, Harrell R, Sorrell A, et al. Addressing PTSD in implantable cardioverter defibrillator patients: state-of-the-art management of ICD shock and PTSD. Curr Cardiol Rep. 2023;25(9):1029–1039. doi: 10.1007/s11886-023-01924-4
  • Blevins CA, Weathers FW, Davis MT, et al. The posttraumatic stress disorder checklist for DSM‐5 (PCL‐5): development and initial psychometric evaluation. J Trauma Stress. 2015;28(6):489–498. doi: 10.1002/jts.22059
  • Thompson DR, Pedersen SS. Psychosocial assessment and psychological interventions following a cardiac event. Heart. 2023 Mar 1;109(5):405–410. doi: 10.1136/heartjnl-2022-321607
  • Eifert GH, Thompson RN, Zvolensky MJ, et al. The cardiac anxiety questionnaire: development and preliminary validity. Behav Res Ther. 2000;38(10):1039–1053. doi: 10.1016/S0005-7967(99)00132-1
  • Mourad G, Strömberg A, Johansson P, et al. Depressive symptoms, cardiac anxiety, and fear of body sensations in patients with non-cardiac chest pain, and their relation to healthcare-seeking behavior: a cross-sectional study. Patient. 2016;9(1):69–77. doi: 10.1007/s40271-015-0125-0
  • Tripp C, Huber NL, Kuhl EA, et al. Measuring ICD shock anxiety: status update on the Florida Shock Anxiety Scale after over a decade of use. PACE. 2019;42(10):1294–1301. doi: 10.1111/pace.13793
  • Kuhl EA, Dixit NK, Walker RL, et al. Measurement of patient fears about implantable cardioverter defibrillator shock: an initial evaluation of the Florida Shock Anxiety Scale. PACE. 2006;29(6):614–618. doi: 10.1111/j.1540-8159.2006.00408.x
  • Burns JL, Serber ER, Keim S, et al. Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey. Cardiovasc Electrophysiol. 2005;16(4):384–390. doi: 10.1046/j.1540-8167.2005.40134.x

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.